RxDoctor Payments Data
★ My doctorsLook up a doctor →

Tara Henderson

Pediatric Hematology-Oncology · Chicago, ILNPI 1386794329

Payments from drug & device makers

What this record shows

This record is dominated by education: $49 of the $49 with a category attached, or 100.0%. United Therapeutics Corporation accounts for 77.1% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for pediatric hematology-oncology clinicians in IL, where the typical reported total is $215.

$49in general payments, 2019–2025

Across 2 payments — averaging $24.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • United Therapeutics Corporation$38
  • Servier Pharmaceuticals LLC$11
$814,072in research payments, 2019–2025

Across 73 payments — averaging $11,152 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$788K
  • Merck$27K

What the payments were for

  • Education$49100%

General payments by program year

20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
United Therapeutics Corporation1$38
Servier Pharmaceuticals LLC1$11

How this compares

$49 in reported general payments places this provider in the 20th percentile of 78 pediatric hematology-oncology providers in Illinois.

See all pediatric hematology-oncology providers in Illinois →

Other pediatric hematology-oncology in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →